← Open Payments lookup

TAIWO AJANI: Open Payments

NPI 1982170213 · LAUREL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,837 in 71 payments from 11 companies in 2025. Trend: 2023 $847 · 2024 $1,034 · 2025 $1,837

Food & beverage: $1,833Education: $4
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$355
ABBVIE INC.13$317
Alkermes, Inc.13$284
Otsuka America Pharmaceutical, Inc.2$153
Supernus Pharmaceuticals, Inc.10$151
Neuronetics, Inc.3$146
E.R. Squibb & Sons, L.L.C.2$140
Axsome Therapeutics, Inc.7$136
Neurocrine BioSciences, Inc.1$114
Lundbeck LLC1$22

Products named: CAPLYTA, VRAYLAR, REXULTI, Qelbree, ARISTADA, NEUROSTAR TMS THERAPY SYSTEM, COBENFY, Auvelity.

Industry payments across MD — which companies pay providers there.